Integra Lifesciences Holdings (IART) Interest Coverage Ratio (2009 - 2026)
Integra Lifesciences Holdings (IART) reported Interest Coverage Ratio of 0.12 for Q1 2026, up 454.11% on a YoY basis from 0.02 in Q1 2025, and down 97.06% sequentially from 4.25 in Q4 2025.
Integra Lifesciences Holdings (IART) Interest Coverage Ratio (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings (IART) has 18 years of Interest Coverage Ratio data on file, last reported at 0.12 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 454.11% year-over-year to 0.12; the trailing twelve-month figure through Mar 2026 stood at 5.08 (down 25029.26% YoY), and the FY2025 full-year result was 5.05, down 1355.43% from the prior year.
- Interest Coverage Ratio fell to 0.12 in Q1 2026, from 4.25 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 6.07 in Q4 2024 to a low of 1.15 in Q2 2025.
- A 5-year average of 0.88 and a median of 0.12 in 2022 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio slumped 3578.97% in 2025 and soared 454.11% in 2026, its largest moves.
- Tracing IART's Interest Coverage Ratio over 5 years: stood at 1.84 in 2022, then soared by 42.16% to 2.62 in 2023, then soared by 131.65% to 6.07 in 2024, then sank by 30.05% to 4.25 in 2025, then plunged by 97.06% to 0.12 in 2026.
- Business Quant data shows IART's Interest Coverage Ratio at 0.12 in Q1 2026, 4.25 in Q4 2025, and 0.04 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.26 Bn | 176.96 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 47.53 Bn | 43.86 Bn | 1.29 Bn | 1.19 |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | 5.36 |
| 7 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | 82.35 |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.41 Bn | 2.07 Bn | -2.90 |
| 10 | Integra Lifesciences Holdings | 1.54 Bn | 1.28 Bn | 216.98 Mn | 0.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.12 |
| Dec 31, 2025 | 4.25 |
| Sep 30, 2025 | 0.04 |
| Jun 30, 2025 | -1.15 |
| Mar 31, 2025 | -0.04 |
| Dec 31, 2024 | 6.07 |
| Sep 30, 2024 | -0.02 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 2.62 |
| Sep 30, 2023 | 0.29 |
| Jun 30, 2023 | 0.05 |
| Mar 31, 2023 | 0.46 |
| Dec 31, 2022 | 1.84 |
| Sep 30, 2022 | 0.25 |
| Jun 30, 2022 | 0.12 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | 1.80 |
| Sep 30, 2021 | 0.10 |
| Jun 30, 2021 | 0.67 |